Press release
Biologics Market 2019 | Rapidly Develop New Product Like Pfizer, Amgen, AstraZeneca, Biogen Idec, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson and Johnson, Merck and Co., Merck KGaA, Novartis
Biologics
New technologies, novel therapies are emerging for the manufacturing of new biologics which holds a prominent future for biologics market. Biologics are widely used to prevent, treat, diagnose, or cure a variety of diseases including cancer, chronic kidney disease, autoimmune disorders, and infectious diseases. Biologics are also used in treatment of rare diseases in children like for treatment of Batten disease, cerliponase alfa was approved in 2017 for the first time by U.S. Food and Drug Administration (FDA).
Free Request Sample of Report: www.coherentmarketinsights.com/insight/request-sample/2663
The biologics market size is expected to boost owing to the increasing product pipeline from different companies like Merck and Co., Pfizer, Glaxosmithkline. Pfizer has a strong product pipeline for 2019 of biologics, biosimilars, vaccines and small molecules. 35 products are in phase 1, 28 are in phase 2 and 26 are in phase 3 and 11 products are in the process of registration. Total 100 products are in trial phase. Most recent approval by Pfizer is DAURISMO (glasdegib) in U.S. for adult patients with newly-diagnosed acute myeloid leukemia for whom intensive chemotherapy is not an option.
Furthermore, the biologics market revenue is growing because of increasing number of Food and Drug Administration (FDA) approvals for new biologic medicines for treatment of rare diseases. For instance, in 2017 US FDA approved 46 biologics and in December 2017, GlaxoSmithKline’s biologic Nucala was approved for the treatment of a rare disease called eosinophilic granulomatosis, with polyangiitis (EPGA).
Inquire about Discount on this Report @ https://www.coherentmarketinsights.com/insight/request-discount/2663
Global Biologics Market: Taxonomy
The global biologics market is segmented on the basis of product type, application, end user, and region.
By Product Type
Monoclonal Antibodies
Vaccines
Recombinant Hormones/Proteins
Cell Therapy
Gene Therapy
By Application
Oncology
Infectious Diseases
Immunology
Autoimmune Diseases
Others
Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Purchase Copy of This Business Research Report: https://www.coherentmarketinsights.com/insight/buy-now/2663
Key players operating in the global biologics market include AbbVie, Amgen, AstraZeneca, Biogen Idec, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson and Johnson, Merck and Co., Merck KGaA, Novartis, Pfizer, F. Hoffmann-La Roche Ltd, and Sanofi.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
About Us:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biologics Market 2019 | Rapidly Develop New Product Like Pfizer, Amgen, AstraZeneca, Biogen Idec, Bristol-Myers Squibb, Eli Lilly and Company, GlaxoSmithKline, Johnson and Johnson, Merck and Co., Merck KGaA, Novartis here
News-ID: 1807304 • Views: …
More Releases from Coherent Market Insights (CMI)
Plastic Surgery Software Market Expands with AI Integration and Patient Visualiz …
The plastic surgery software industry is witnessing transformative growth, driven by increased digital adoption and a rising demand for enhanced clinical outcomes and patient management solutions. The market's evolution focuses on providing integrated platforms to streamline appointment scheduling, patient records, and procedural planning. This dynamic shift embodies the changing landscape of surgical practices globally, showcasing significant potential for business growth.
Market Size and Overview
The Plastic Surgery Software market size is…
Food And Beverage Robotic System Integration For Pick And Place Application Mark …
Global Food And Beverage Robotic System Integration For Pick And Place Application Market Growing Demand and Growth Opportunity 2025-2032:
The Coherent Market Insights A new report research on the Food And Beverage Robotic System Integration For Pick And Place Application Market Share from 2025 to 2032 provides accurate economic, global, and country-level predictions and analyses. It presents a comprehensive view of the competitive landscape, along with a detailed supply chain analysis…
Pharmaceutical Drug Delivery Market Expected to Expand at a Steady 2024-2031 | J …
The latest market intelligence report published by CMI with the title "Global Pharmaceutical Drug Delivery Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Pharmaceutical industry. The report provides demand analysis, industry insights, competitive intelligence, and customer database.
The Research report on Pharmaceutical Drug Delivery Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing…
Huge Growth in Mobile Imaging Services Market 2023 to see Future Opportunities 2 …
𝗢𝘃𝗲𝗿𝘃𝗶𝗲𝘄:
Mobile imaging services are provided by trained professionals who are equipped with state-of-the-art imaging technology that can be transported and set up on location. The images obtained through mobile imaging services are then transmitted electronically to the patient's healthcare provider for analysis and diagnosis.
Mobile imaging services are used in a variety of healthcare settings, including hospitals, clinics, nursing homes, and home health agencies. They are particularly useful for imaging patients…
More Releases for Biologics
Biologics Contract Manufacturing Market to Hit US$ 83.47 Billion by 2033 | Top C …
Biologics Contract Manufacturing Market reached US$ 26.03 billion in 2024 and is expected to reach US$ 83.47 billion by 2033, growing at a CAGR of 14.0% during the forecast period 2025-2033.
Download your exclusive sample report today (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/biologics-contract-manufacturing-market?prasad
DataM Intelligence unveils exclusive insights into the Biologics Contract Manufacturing Market 2026, highlighting emerging trends, growth drivers, and key regional opportunities worldwide. The report helps solve critical business challenges by…
Platinum Biologics Highlights Rising Consumer Confusion in the Biologics Market
[Orlando, USA - March 27, 2026] - A growing wave of consumer uncertainty is reshaping how patients and buyers approach the biologics market, particularly in emerging categories such as exosomes. As interest accelerates, so does confusion-driven by inconsistent standards, complex terminology, and a flood of marketing claims that are difficult for non-experts to verify.
Recent observations shared by Platinum Biologics point to a clear behavioral shift: consumers are no longer relying…
Biologics CDMO Services Market is Booming Worldwide | Lonza Group, Catalent, Sam …
The latest study released on the Global Biologics CDMO Services Market by HTF MI Research evaluates market size, trend, and forecast to 2033. The Biologics CDMO Services study covers significant research data and proofs to be a handy resource document for managers, analysts, industry experts and other key people to have ready-to-access and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges and about the competitors.
Major…
Global Biologics Contract Manufacturing Market Set to Reach $83.47 Billion by 20 …
Biologics Contract Manufacturing Market reached US$ 26.03 billion in 2024 and is expected to reach US$ 83.47 billion by 2033, growing at a CAGR of 14.0% during the forecast period 2025-2033.
The Biologics Contract Manufacturing market involves outsourcing the production of complex biologic drugs, including vaccines, antibodies, and recombinant proteins. Rising demand for biologics, cost-effective manufacturing, and scalable production drives growth. Technological advancements in cell culture, purification, and quality control enhance…
Advanced Biologics Manufacturing Solutions Market Future Business Opportunities …
The qualitative latest Research report (2025-2032) on the Advanced Biologics Manufacturing Solutions Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves.
Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/137417
Focused on…
Biologics Market
The "Biologics Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Biologics Market, 2024-2031
Verified Market Research's most recent report, "Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination of the industry…
